so many biotechs, so many companies in advanced trials, so many multi-billion dollar pill markets, surely they can't ALL be successful? The q is, how do you pick the ones that will go all the way to a successful drug release? I don't have a solution, but my strategy is to go with external reviews of progress and potential, and those for ANP have been pretty interesting.
